Scophthalmus maximus cystatin B enhances head kidney macrophage-mediated bacterial killing

Developmental and Comparative Immunology

Volumn 34, Issue 12, 2010, Pages 1237-1241

  Xiao, Ping Ping ^a,b   Hu, Yong Hua ^a   Sun, Li ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Bacterial infection; Cystatin B; Macrophage; Scophthalmus maximus

Indexed keywords

COMPLEMENTARY DNA; CYSTATIN B; NITRIC OXIDE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BLOOD; BRAIN; ESCHERICHIA COLI; GILL; HEART; INNATE IMMUNITY; KIDNEY; LIVER; MACROPHAGE; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SPLEEN; START CODON; TURBOT; UPREGULATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; SCOPHTHALMIDAE; SCOPHTHALMUS MAXIMUS;

EID: 77956943972     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2010.07.008     Document Type: Article

References (32)

1. Abrahamson M., Alvarez-Fernandez M., Nathanson C.M. Cystatins Biochem. Soc. Symp. 2003, 70:179-199.
2. Bode W., Engh R., Musil D., Thiele U., Huber R., Karshikov A., Brzin J., Kos J., Turk V. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 1988, 7:2593-2599.
3. Calkins C.C., Sloane B.F. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol. Chem. Hoppe Seyler 1995, 376:71-80.
4. Engh R.A., Dieckmann T., Bode W., Auerswald E.A., Turk V., Huber R., Oschkinat H. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy. J. Mol. Biol. 1993, 234:1060-1069.
5. Graham S., Jeffries A.H., Secombes C.J. A novel assay to detect macrophage bactericidal activity in fish: factors influencing the killing of Aeromonas salmonicida. J. Fish Dis. 1988, 11:389-396.
6. Hashimoto S., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
7. Henskens Y.M., Veerman E.C., Nieuw Amerongen A.V. Cystatins in health and disease. Biol. Chem. Hoppe Seyler 1996, 377:71-86.
8. Hu Y., Zheng W., Sun L. Identification and molecular analysis of a ferritin subunit from red drum (Sciaenops ocellatus). Fish Shellfish Immunol. 2010, 28:678-686.
9. Joensuu T., Lehesjoki A.E., Kopra O. Molecular background of EPM1-Unverricht-Lundborg disease. Epilepsia 2008, 49:557-563.
10. Kopitar-Jerala N. The role of cystatins in cells of the immune system. FEBS Lett. 2006, 580:6295-6301.
11. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987, 15:8125-8148.
12. Lalioti M.D., Mirotsou M., Buresi C., Peitsch M.C., Rossier C., Ouazzani R., et al. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am. J. Hum. Genet. 1997, 60:342-351.
13. Lefebvre C., Cocquerelle C., Vandenbulcke F., Hot D., Huot L., Lemoine Y., Salzet M. Transcriptomic analysis in the leech Theromyzon tessulatum: involvement of cystatin B in innate immunity. Biochem. J. 2004, 380:617-625.
14. Liu C., Sun Y., Hu Y., Sun L. Identification and analysis of a CpG motif that protects turbot (Scophthalmus maximus) against bacterial challenge and enhances vaccine-induced specific immunity. Vaccine 2010, 28:4153-4161.
15. Martin J.R., Craven C.J., Jerala R., Kroon-Zitko L., Zerovnik E., Turk V., Waltho J.P. The three dimensional solution structure of human stefin A. J. Mol. Biol. 1995, 246:331-343.
16. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J., D'Amato E., Ramirez L., Faham M., Koskiniemi M., Warrington J.A., Norio R., de la Chapelle A., Cox D.R., Myers R.M. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996, 271:1731-1734.
17. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 1998, 20:251-258.
18. Rodríguez I., Novoa B., Figueras A. Immune response of zebrafish (Danio rerio) against a newly isolated bacterial pathogen Aeromonas hydrophila. Fish Shellfish Immunol. 2008, 25:239-249.
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y. 2nd ed.
20. Sol-Church K., Picerno G.N., Stabley D.L., Frenck J., Xing S., Bertenshaw G.P., Mason R.W. Evolution of placentally expressed cathepsins. Biochem. Biophys. Res. Commun. 2002, 293:23-29.
21. Stubbs M.T., Laber B., Bode W., Huber R., Jerala R., Lenarcic B., Turk V. The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 1990, 9:1939-1947.
22. Suzuki T., Hashimoto S., Toyoda N., Nagai S., Yamazaki N., Dong H.Y., Sakai J., Yamashita T., Nukiwa T., Matsushima K. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000, 96:2584-2591.
23. Turk V., Bode W. The cystatins: proteins inhibitors of cysteine proteinases. FEBS Lett. 1991, 285:213-219.
24. Turk V., Stoka V., Turk D. Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. 2008, 13:5406-5420.
25. Verdot L., Lalmanach G., Vercruysse V., Hartmann S., Lucius R., Hoebeke J., et al. Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J. Biol. Chem. 1996, 271:28077-28081.
26. Verdot L., Lalmanach G., Vercruysse V., Hoebeke J., Gauthier F., Vray B. Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis. Eur. J. Biochem. 1999, 266:1111-1117.
27. Vray B., Hartmann S., Hoebeke J. Immunomodulatory properties of cystatins. Cell. Mol. Life Sci. 2002, 59:1503-1512.
28. Wynne J.W., O'Sullivan M.G., Cook M.T., Stone G., Nowak B.F., Lovell D.R., Elliott N.G. Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression. Mar. Biotechnol. (N.Y.) 2008, 10:388-403.
29. Zavasnik-Bergant T. Cystatin protease inhibitors and immune functions. Front. Biosci. 2008, 13:4625-4637.
30. Zhang M., Sun K., Sun L. Regulation of autoinducer 2 production and luxS expression in a pathogenic Edwardsiella tarda strain. Microbiology 2008, 154:2060-2069.
31. Vh, a serine protease and a protective immunogen from a pathogenic Vibrio harveyi strain. Appl. Environ. Microbiol. 2008, 74:6254-6262.
32. Zheng W., Hu Y., Sun L. Cloning and analysis of a ferritin subunit from turbot (Scophthalmus maximus). Fish Shellfish Immunol. 2010, 28:829-836.